PURE Innovation Biotech is a research‑driven company focused on discovery biology, platform engineering, and GMP‑ready development. We partner with academia and industry to move ideas from the bench to real‑world impact.
We signed a multi‑year R&D collaboration focused on oncology and rare diseases.
Our latest work demonstrates 10× stability gains using directed evolution and ML.
New lab space and instrumentation expand capacity for small‑scale manufacturing.
We find new therapies using bioproteins — combining discovery biology, protein engineering, and data science to translate insights into real‑world impact.
Target and pathway insights from omics & AI‑assisted mining.
Stability, activity, and developability tuned with rational design.
Assays and models that de‑risk development for partners and programs.
Advancing programs with bio-generational molecules.
1 registered patent and 4 provisional filings.
Co-development with partners; details under NDA.
NGS workflows, variant analysis, and CRISPR screening.
Rational design and directed evolution platforms.
Stable cell lines, primary cells, and assay‑ready models.
Pipelines for omics, structure prediction, and data viz.
Generative design, property prediction, and automation.
LC‑MS, ELISA, HPLC, and orthogonal characterization.
Scalable upstream/downstream process optimization.
GxP‑aligned documentation, QA/QC, and validation.
Liquid handling, data capture, and reproducible SOPs.
Green chemistry and responsible sourcing.